Status | Study |
RECRUITING |
Study Name: A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL) Condition: Lymphoblastic Lymphoma Date: 2023-05-23 Interventions: A single dose of BEAM-201 administered by IV following one of two lymphodepletion regimens |
Not yet recruiting |
Study Name: Study of Clofarabine, Etoposide, Cyclophosphamide [CEC], Liposomal Vincristine (VCR), Dexamethasone and Bortezomib in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL) Condition: Hematopoietic/Lymphoid Cancer Acute Lymphoblastic Leukemia Date: 2017-04-27 Interventions: Drug: Clofarabine |
Recruiting |
Study Name: Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia Condition: T-cell Type Acute Leukemia-Precursor T-lymphoblastic Lymphoma/Leukaemia Date: 2016-12-19 Interventions: Drug: Isatuximab SAR650984 Pha |
Recruiting |
Study Name: Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment Condition: Acute Lymphoblastic Leukemia Lymphoblastic Lymphoma Date: 2016-08-04 Interventions: Drug: Rituximab Drug: Nelarabine |
Recruiting |
Study Name: LBL-2016 for Children or Adolescents in China Condition: Lymphoblastic Lymphoma Date: 2016-07-24 Interventions: Drug: Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosp |
Recruiting |
Study Name: BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma Condition: T-Acute Lymphoblastic Leukemia Adult T Lymphoblastic Lymphoma Date: 2016-05-03 Interventions: Drug: BL-8040 Drug: Nelarabine |
Not yet recruiting |
Study Name: Standard Maintenance POMP/D Plus Ixazomib Maintenance Therapy in Adult Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR) Condition: Acute Lymphoblastic Leukemia in Complete Remission Lymphoblastic Lymph Date: 2015-09-30 Interventions: Drug: Ixazomib Patients who have been on stable doses of 6 - MP, vincristine, and methotrexate for a min |
Recruiting |
Study Name: Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults Condition: Acute Lymphoblastic Leukemia Lymphoblastic Lymphoma Date: 2015-08-04 Interventions: Drug: Velcade 4 doses of study |
Recruiting |
Study Name: Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Condition: Leukemia Precursor-B Acute Lymphoblastic Leukemia Date: 2015-04-14 Interventions: Drug: Cytarabine |
Recruiting |
Study Name: Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma Condition: Lymphoma, Lymphoblastic Date: 2015-03-18 Interventions: Drug: induction |